It seems axiomatic to us that the world is increasingly turning to China as a place to discover, develop and manufacture biopharmaceutical products. However, Charles River Labs (CRL) said last week that its experience as a CRO in China has been that its contract work comes from local China companies (see story). Charles River has labs around the world, and it has recently established a presence in China as well.

Original URL: Click here to visit original article
Copyright China Stocks News and Analysis from Seeking Alpha

It seems axiomatic to us that the world is increasingly turning to China as a place to discover, develop and manufacture biopharmaceutical products. However, Charles River Labs (CRL) said last week that its experience as a CRO in China has been that its contract work comes from local China companies (see story). Charles River has labs around the world, and it has recently established a presence in China as well.

Original URL: Click here to visit original article
Copyright China Stocks News and Analysis from Seeking Alpha